Atlas Trials

Study of GemOx and Vandetanib in Advanced Solid Malignancy

Clinical trial NCT00660725 · COMPLETED

Trial details

NCT number
NCT00660725
Sponsor
Leonard Appleman
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Incurable Solid Malignancy
Start date
2009-02-01
Primary completion
2010-11-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.